EZZ Life Science Holdings Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	61.4	66.87	66.44	37.14	15.02	22.29
Revenue	61.4	66.87	66.44	37.14	15.02	22.29
Revenue Growth (YoY)	-18.17%	0.65%	78.88%	147.26%	-32.60%	24.03%
Cost of Revenue	16.78	17.15	15.5	8.61	7.51	9.83
Gross Profit	44.62	49.72	50.95	28.53	7.51	12.46
Selling, General & Admin	33.13	35.87	38.49	21.7	4.14	8.68
Other Operating Expenses	4.85	3.41	2.35	2.03	1.46	0.9
Operating Expenses	39.36	39.79	41.23	23.91	5.72	9.71
Operating Income	5.26	9.93	9.72	4.62	1.78	2.75
Interest Expense	-0.03	-0.03	-0.02	-0.01	-0	-0.01
Interest & Investment Income	0.39	0.42	0.2	0.04	0	-
Currency Exchange Gain (Loss)	0.24	0.24	0.07	0.22	-	-
Other Non Operating Income (Expenses)	0.03	0.03	-	0.04	-	-
Pretax Income	5.88	10.59	9.96	4.9	1.78	2.74
Income Tax Expense	2.99	3.86	2.99	1.27	0.47	0.71
Net Income	2.89	6.73	6.96	3.63	1.31	2.03
Net Income to Common	2.89	6.73	6.96	3.63	1.31	2.03
Net Income Growth	-67.94%	-3.36%	91.87%	176.57%	-35.37%	28.02%
Shares Outstanding (Basic)	47	46	43	43	43	34
Shares Outstanding (Diluted)	47	46	43	43	43	34
Shares Change (YoY)	6.22%	7.35%	0.89%	0.46%	25.23%	13.15%
EPS (Basic)	0.06	0.15	0.16	0.08	0.03	0.06
EPS (Diluted)	0.06	0.15	0.16	0.08	0.03	0.06
EPS Growth	-69.81%	-9.99%	90.19%	175.31%	-48.37%	13.10%
Free Cash Flow	-2.69	4.13	5.73	3.91	1.9	0.25
Free Cash Flow Per Share	-0.06	0.09	0.13	0.09	0.04	0.01
Dividend Per Share	0.020	0.040	0.035	0.020	0.004	0.004
Dividend Growth	-50.00%	14.29%	76.77%	340.00%	-	-
Gross Margin	72.67%	74.35%	76.68%	76.81%	49.98%	55.90%
Operating Margin	8.56%	14.85%	14.62%	12.43%	11.88%	12.33%
Profit Margin	4.71%	10.06%	10.48%	9.77%	8.74%	9.11%
Free Cash Flow Margin	-4.38%	6.17%	8.63%	10.53%	12.62%	1.11%
EBITDA	5.42	10.08	9.75	4.63	1.8	2.76
EBITDA Margin	8.82%	15.08%	14.68%	12.48%	11.98%	12.41%
D&A For EBITDA	0.16	0.15	0.03	0.02	0.02	0.02
EBIT	5.26	9.93	9.72	4.62	1.78	2.75
EBIT Margin	8.56%	14.85%	14.62%	12.43%	11.88%	12.33%
Effective Tax Rate	50.86%	36.42%	30.07%	25.93%	26.26%	25.80%
Advertising Expenses	-	32.27	37.23	20.56	2.97	7.84

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.